Sigma Healthcare Limited Cash Flow Conversion Efficiency

Latest as of January 2023: 0.047x

Sigma Healthcare Limited cash flow conversion efficiency. Based on the latest financial reports, Sigma Healthcare Limited (S5YA) has a cash flow conversion efficiency ratio of 0.047x as of January 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€22.39 Million ≈ $26.18 Million USD) by net assets (€477.77 Million ≈ $558.56 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Sigma Healthcare Limited (2017–2023)

Cash flow conversion efficiency of Sigma Healthcare Limited from 2017 to 2023. This chart illustrates how Sigma Healthcare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View S5YA share price today for real-time trading data and today's change.

Sigma Healthcare Limited Cash Flow Conversion Ratio Explained

Sigma Healthcare Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Sigma Healthcare Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sigma Healthcare Limited ranked by their cash flow conversion efficiency. Also see S5YA market cap for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Kyocera Corporation
F:KYRA
0.026x
Fubon Financial Holding Co Ltd Pref
TW:2881A
0.005x
First Financial Holding Co Ltd
TW:2892
0.064x
EXACT Sciences Corporation
NASDAQ:EXAS
0.063x
China Development Financial Holding Corp
TW:2883
-0.072x
Weichai Power Co Ltd Class A
SHE:000338
0.102x
HUATEI SECS.CO GDR S/10
F:206G
N/A
Lennar Corporation
NYSE:LEN
0.079x

Annual Cash Flow Conversion Efficiency for Sigma Healthcare Limited (2017–2023)

The table below shows the annual cash flow conversion efficiency of Sigma Healthcare Limited from 2017 to 2023. Review cash generation quality of Sigma Healthcare Limited to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2023-01-31 €477.77 Million
≈ $558.56 Million
€142.74 Million
≈ $166.88 Million
0.299x +415.53%
2022-01-31 €488.78 Million
≈ $571.43 Million
€-46.28 Million
≈ $-54.11 Million
-0.095x -285.89%
2021-01-31 €534.90 Million
≈ $625.36 Million
€-13.12 Million
≈ $-15.34 Million
-0.025x -105.77%
2020-01-31 €476.74 Million
≈ $557.36 Million
€202.75 Million
≈ $237.04 Million
0.425x +2482.27%
2019-01-31 €514.28 Million
≈ $601.25 Million
€8.47 Million
≈ $9.90 Million
0.016x -88.08%
2018-01-31 €515.26 Million
≈ $602.39 Million
€71.18 Million
≈ $83.22 Million
0.138x -48.96%
2017-01-31 €538.59 Million
≈ $629.66 Million
€145.77 Million
≈ $170.42 Million
0.271x --

About Sigma Healthcare Limited

F:S5YA Germany Medical Distribution
Market Cap
$22.54 Billion
€19.28 Billion EUR
Market Cap Rank
#1268 Global
#290 in Germany
Share Price
€1.67
Change (1 day)
-0.60%
52-Week Range
€1.52 - €1.84
All Time High
€1.93
About

Sigma Healthcare Limited operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies primarily in Australia. It offers support services to a network of franchised retail pharmacies; third and fourth party logistics services to pharmaceutical manufacturers and other supplier partners; and health services. The company operates stores under the Chemi… Read more